News Archive

In a 9-12 vote, lawmakers in Montana have voted against a bill to legalize psilocybin therapy.

Historically, it's been seen as helpful for psychotherapists to experience the therapeutic models they provide to patients. With this in mind, the increasing interest in psychedelic therapy poses the question: should psychedelic therapists have personal experience using psychedelics?

A new study has produced detailed brain imaging that seeks to answer a key question about psychedelics: how does DMT affect the brain?

Oregon has approved the first psilocybin grower license to supply the state's upcoming psychedelic therapy service centres.

A Eugene, Oregon-based therapist is documenting the cost of psilocybin therapy from a practitioner's point of view, and it's higher than many people expected.

Psychedelics, particularly MDMA, have the potential to revolutionize couple's therapy.

New research from UC Davis may be the first step to understanding one of the key questions about psychedelic medicine: how do psychedelics work, and what makes them different from other mental health medications?

Synthesis Institute, formerly positioned as the 'gold standard' of psychedelic training, has folded

Research out of NYU supports the use of psilocybin for alcohol use disorder: participants treated with psilocybin reported reduced heavy drinking compared to the placebo group.

A new study has found that physical activity is beneficial in treating depression, anxiety, and psychological distress.